- Home
- CLLS vs ELMD Comparison
CLLS vs ELMD Comparison
Compare CLLS & ELMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLLS | ELMD |
|---|---|---|
| Founded | 1999 | 1992 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 394.4M | 326.9M |
| IPO Year | 2014 | 2010 |
Fundamental Metrics
Financial Performance| Metric | CLLS | ELMD |
|---|---|---|
| Price | $3.40 | $39.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $8.33 | ★ $36.00 |
| AVG Volume (30 Days) | 16.1K | ★ 48.1K |
| Earning Date | 05-08-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 46.55 |
| EPS | N/A | ★ 0.91 |
| Revenue | N/A | ★ $54,716,000.00 |
| Revenue This Year | N/A | $15.59 |
| Revenue Next Year | $0.98 | $11.51 |
| P/E Ratio | ★ N/A | $43.96 |
| Revenue Growth | N/A | ★ 13.83 |
| 52 Week Low | $2.35 | $19.93 |
| 52 Week High | $5.48 | $47.40 |
Technical Indicators
Market Signals| Indicator | CLLS | ELMD |
|---|---|---|
| Relative Strength Index (RSI) | 68.24 | 44.85 |
| Support Level | $3.41 | $35.61 |
| Resistance Level | $4.24 | $43.61 |
| Average True Range (ATR) | 0.18 | 1.41 |
| MACD | 0.08 | -0.22 |
| Stochastic Oscillator | 99.12 | 19.53 |
Price Performance
Historical ComparisonAbout CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.